Last $7.10 USD
Change Today +0.16 / 2.31%
Volume 772.0K
VNDA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 3:35 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John J. Feeney III, M.D.

Former Chief Medical Officer, Vanda Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

57$720,388
As of Fiscal Year 2012

Background*

Dr. John J. Feeney, III, M.D has been Chief Medical Officer of Vanda Pharmaceuticals, Inc., since March 24, 2010 until September 12th, 2012 and served as its Senior Vice President. Dr. Feeney served as an Acting Chief Medical Officer of Vanda Pharmaceuticals, Inc. since January 9, 2009. Dr. Feeney served as Vanda Pharmaceuticals, Inc.'s Senior Medical Officer since November 2007. He spent more than 15 years at the FDA in various capacities, including Medical Officer ...

Read Full Background

Corporate Headquarters*

2200 Pennsylvania Avenue NW
Washington, District Of Columbia 20037

United States

Phone: 202-734-3400
Fax: 202-296-1450

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of California - San Diego
MD
Georgetown University School Of Medicine

Other Affiliations*

Annual Compensation*

Salary$224,205
Total Annual Compensation$224,205

Stock Options*

All Other Compensation$496,183
Exercisable Options197,214
Exercisable Options Value$29,314
Total Value of Options$29,314
Total Number of Options197,214

Total Compensation*

Total Annual Cash Compensation$720,388
Total Short Term Compensation$224,205
Other Long Term Compensation$496,183
Total Calculated Compensation$720,388
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNDA:US $7.10 USD +0.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard Solomon Chairman, Chief Executive Officer and President
Forest Laboratories Inc.
$2.4M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
610.0K GBP
Ulf Arne Wiinberg Chief Executive Officer, President and Member of the Board of Management
H. Lundbeck A/S
--
Masayo Tada Chief Executive Officer, President, Director and Chairman of Risk Management Committee
Dainippon Sumitomo Pharma Co., Ltd.
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANDA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.